Home > Browse Research > Life Sciences > Pharmaceuticals > Biopharmaceuticals

Biopharmaceuticals: market research reports

Biosimilars (129)

Biopharmaceuticals market research reports and industry analysis

Phytosterols and Phytostanols - Patent and Technology Report - Key players, innovators and Industry Analysis 11/17/2011 \| published by: Dolcera Corporation ... Stanols are saturated sterols which are not abundant in nature and produced by the hydrogenation of sterols. Phytosterols are used in pharmaceuticals (production of therapeutic steroids), nutrition (anti-cholesterol additives in functional foods, anti-cancer properties), and ... \| read more...	$999.00
Phytosterols and Phytostanols - Patent and Technology Landscape Report - Key players, innovators and industry analysis 11/17/2011 \| published by: Dolcera Corporation ... Stanols are saturated sterols which are not abundant in nature and produced by the hydrogenation of sterols. Phytosterols are used in pharmaceuticals (production of therapeutic steroids), nutrition (anti-cholesterol additives in functional foods, anti-cancer properties), and ... \| read more...	$999.00
Canada: Generics and Biosimilars Overview 11/3/2011 \| published by: Datamonitor ... players. In terms of biosimilars, referred to as subsequent entry biologics (SEBs), Health Canada in March 2010 published its regulatory guidance for the approval of SEBs. Features and benefits Compares the Canadian generics market in ... \| read more...	$1,900.00
Multi-therapy Drugs: Opportunities for Generics & Biosimilars 10/25/2011 \| published by: Espicom Healthcare Intelligence Highly-detailed analysis, outlook & forecasts of 24 leading drugs which are indicated for a range of critical conditions. \| read more...	$1,740.00
Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020) 10/17/2011 \| published by: IMARC ... be more akin to a marathon than a sprint. IMARC Group, one of the world’s leading research and advisory firms, in its new report “Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US ... \| read more...	$1,200.00
Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition 10/15/2011 \| published by: Kalorama Information ... extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects. Growth in the development and production of biopharmaceuticals is ... \| read more...	$3,500.00
Freedonia Focus on Biologics 9/30/2011 \| published by: Freedonia Focus Reports ... industry composition and leading participants. Product segments include monoclonal antibodies (MAbs), vaccines and toxoids, hormones, growth factors, immunomodulators, and other biologics. Market segments cover human healthcare (cancer, autoimmune disorders, infectious disease, blood disorders, diabetes and ... \| read more...	$600.00
Biologics Price Competition and Innovation (BPCI) Act - Industry Trends Creating Demand for Biosimilars 9/30/2011 \| published by: GlobalData ... Creating Demand for Biosimilars”. The report is an essential source of information and analysis on the global biosimilar market opportunity. The report identifies the key trends shaping and driving the global biosimilars market. The report ... \| read more...	$500.00
Conference Documentation: Biosimilars and Biobetters 9/27/2011 \| published by: SMI Publishing, Ltd ... the progress made in last year’s meeting and further develop the ideas and strategies that were debated and discussed. Specifically, how can the pharma and generics industries best approach the rapidly emerging and developing biosimilar ... \| read more...	$800.00
Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research 9/23/2011 \| published by: Frost & Sullivan ... of various binding abilities, prepacked columns/cartridges filled with a particular resin, and complete kits. Affinity tags are widely used for protein purification due to the ability to achieve high-purity proteins in a single step. The ... \| read more...	$6,000.00
Biosimilars: China Update 9/22/2011 \| published by: Datamonitor ... a growing shift towards the development of both novel and biogeneric monoclonal antibodies and second-generation biologics.An overview of biologic regulations in China Insight into the key drivers and resistors to biogeneric uptake in the China ... \| read more...	$1,900.00
Biosimilars: Japan Update 9/13/2011 \| published by: Datamonitor ... and brand-loyal nature of the Japanese market means that uptake will be slow, with only the larger, more well-known players likely to succeed.An overview of the Japanese biosimilars market and its application pathway. Insight into ... \| read more...	$1,900.00
Biosimilar Opportunities: Pipelines and Companies 9/1/2011 \| published by: Decision Resources ... in the major markets and more products reaching later stages of development. The lure of biosimilars is also enticing companies outside the pharmaceutical arena to develop biosimilars capabilities-an interest that emphasizes the potential size of ... \| read more...	$4,600.00
Biologics 9/1/2011 \| published by: Freedonia Group Inc ... dramatic shifts in production technology and expansion of targeted diseases, and challenged by the introduction of biosimilar products following patent expiry of major biologic products. Monoclonal antibodies to benefit from biotech boom Biologics such as ... \| read more...	$4,900.00
Success with Biobetters: Young Biobetters Companies and Pipelines 9/1/2011 \| published by: Decision Resources ... as biosuperiors). Biobetters are created by building additional properties into the originator biologic through glycosylation, amino acid changes, or conjugation to other components that make the new protein better than the originator biologic. The biobetters ... \| read more...	$4,600.00
Hot Topics in Multiple Sclerosis: US Prescriber Perception of Biosimilars - Brands to lose over a fifth of patients to copy-cat drugs 8/31/2011 \| published by: Datamonitor ... next decade. Datamonitor conducted a survey of 50 US neurologists to ascertain the future impact of biosimilars on their prescribing patterns.Understand the factors that make multiple sclerosis an attractive opportunity for biosimilar developers. Gauge the ... \| read more...	$3,800.00
Biosimilar: Regulatory Update 8/9/2011 \| published by: Datamonitor ... the EU, the EMA is furthering development of approval pathways for biosimilar monoclonal antibodies Features and benefits Provides global biosimilar sales (2008-10), in addition to the status of biosimilar approval pathways across the globe. Insight ... \| read more...	$395.00
South Korea: Generics and Biosimilars Overview 8/8/2011 \| published by: Datamonitor ... trend towards development of incrementally modified drugs offers multinational companies facing patent expiries lucrative partnering opportunities with global potential. Features and benefits Insight into the key drivers and resistors to generics uptake in South Korea. ... \| read more...	$395.00
Electronic Laboratory Notebooks (ELNs) 8/1/2011 \| published by: Global Industry Analysts ... Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period of 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 37 companies including ... \| read more...	$4,800.00
Hospital Injectable Drugs: Future Prospects for Generics & Biosimilars 7/25/2011 \| published by: Espicom Healthcare Intelligence The generic injectables sector exceeds US$11.2 billion and numerous high-value injectable products will face patent expiry in major markets over the next decade. This critical new report evaluates the markets, players and products in detail. \| read more...	$2,265.00
Mexico: Generics and Biosimilars Overview 7/7/2011 \| published by: Datamonitor ... preference for low-cost pharmaceuticals and the growth of health insurance is set to drive the uptake of GIs. Features and benefits Compares the Mexican generics market in value and volume terms to other leading developed ... \| read more...	$1,900.00
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics 7/1/2011 \| published by: Kalorama Information ... analysis in this report. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry and the needle-free drug delivery market will continue to grow rapidly. This ... \| read more...	$2,995.00
Global Biosimilars Market Analysis 7/1/2011 \| published by: RNCOS ... the global biosimilars industry. According to our new research report “Global Biosimilars Market Analysis”, the global biosimilars market is anticipated to grow at a CAGR of around 52% during 2010-2015. Market growth will be driven ... \| read more...	$1,400.00
Turkey: Generics and Biosimilars Overview 6/29/2011 \| published by: Datamonitor ... property laws allowing the earlier launch of generics compared to other European markets, and pharmacist substitution. Features and benefits Insight into the key drivers and resistors to generics uptake in Turkey. Assesses strategies employed by ... \| read more...	$1,900.00
2011 Outsourcing Guide for the Drugs & Biotechnology Industry 6/15/2011 \| published by: Information Services Group (ISG) ... within the Drugs & Biotechnology vertical and subvertical levels, including 'Pharmaceuticals & Biopharmaceuticals' and Distribution & Medical Instrumentation'. This report from the TPI Momentum Market Trends & Insights series can help service providers develop an ... \| read more...	$1,500.00

< prev 1 2 3 4 5 6 7 8 9 10 next >